7nw2
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-47== | ==Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-47== | ||
| - | <StructureSection load='7nw2' size='340' side='right'caption='[[7nw2]]' scene=''> | + | <StructureSection load='7nw2' size='340' side='right'caption='[[7nw2]], [[Resolution|resolution]] 2.10Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7NW2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7NW2 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[7nw2]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/2019-ncov 2019-ncov]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7NW2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7NW2 FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7nw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7nw2 OCA], [https://pdbe.org/7nw2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7nw2 RCSB], [https://www.ebi.ac.uk/pdbsum/7nw2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7nw2 ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=USZ:~{N}-(4-~{tert}-butylphenyl)-~{N}-[(1~{R})-2-[2-(3-fluorophenyl)ethylamino]-2-oxidanylidene-1-pyridin-3-yl-ethyl]propanamide'>USZ</scene></td></tr> |
| + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[https://en.wikipedia.org/wiki/SARS_coronavirus_main_proteinase SARS coronavirus main proteinase], with EC number [https://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.22.69 3.4.22.69] </span></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7nw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7nw2 OCA], [https://pdbe.org/7nw2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7nw2 RCSB], [https://www.ebi.ac.uk/pdbsum/7nw2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7nw2 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [[https://www.uniprot.org/uniprot/R1A_SARS2 R1A_SARS2]] Multifunctional protein involved in the transcription and replication of viral RNAs. Contains the proteinases responsible for the cleavages of the polyprotein.[UniProtKB:P0C6X7] Inhibits host translation by interacting with the 40S ribosomal subunit. The nsp1-40S ribosome complex further induces an endonucleolytic cleavage near the 5'UTR of host mRNAs, targeting them for degradation. Viral mRNAs are not susceptible to nsp1-mediated endonucleolytic RNA cleavage thanks to the presence of a 5'-end leader sequence and are therefore protected from degradation. By suppressing host gene expression, nsp1 facilitates efficient viral gene expression in infected cells and evasion from host immune response.[UniProtKB:P0C6X7] May play a role in the modulation of host cell survival signaling pathway by interacting with host PHB and PHB2. Indeed, these two proteins play a role in maintaining the functional integrity of the mitochondria and protecting cells from various stresses.[UniProtKB:P0C6X7] Responsible for the cleavages located at the N-terminus of the replicase polyprotein. In addition, PL-PRO possesses a deubiquitinating/deISGylating activity and processes both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular substrates. Participates together with nsp4 in the assembly of virally-induced cytoplasmic double-membrane vesicles necessary for viral replication. Antagonizes innate immune induction of type I interferon by blocking the phosphorylation, dimerization and subsequent nuclear translocation of host IRF3. Prevents also host NF-kappa-B signaling.[UniProtKB:P0C6X7] Participates in the assembly of virally-induced cytoplasmic double-membrane vesicles necessary for viral replication.[UniProtKB:P0C6X7] Cleaves the C-terminus of replicase polyprotein at 11 sites. Recognizes substrates containing the core sequence [ILMVF]-Q-|-[SGACN]. Also able to bind an ADP-ribose-1''-phosphate (ADRP).[UniProtKB:P0C6X7] Plays a role in the initial induction of autophagosomes from host reticulum endoplasmic. Later, limits the expansion of these phagosomes that are no longer able to deliver viral components to lysosomes.[UniProtKB:P0C6X7] Forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.[UniProtKB:P0C6X7] Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.[UniProtKB:P0C6X7] May participate in viral replication by acting as a ssRNA-binding protein.[UniProtKB:P0C6X7] Plays a pivotal role in viral transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16 2'-O-methyltransferase activities. Therefore plays an essential role in viral mRNAs cap methylation.[UniProtKB:P0C6X7] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found approximately 11,000 cysteines proximal to a ligand across 8,386 complexes in the PDB. Of these, the protocol identified 1,553 structures with covalent predictions. In a prospective evaluation, five out of nine predicted covalent kinase inhibitors showed half-maximal inhibitory concentration (IC50) values between 155 nM and 4.5 muM. Application against an existing SARS-CoV M(pro) reversible inhibitor led to an acrylamide inhibitor series with low micromolar IC50 values against SARS-CoV-2 M(pro). The docking was validated by 12 co-crystal structures. Together these examples hint at the vast number of covalent inhibitors accessible through our protocol. | ||
| + | |||
| + | An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M(pro) inhibitor.,Zaidman D, Gehrtz P, Filep M, Fearon D, Gabizon R, Douangamath A, Prilusky J, Duberstein S, Cohen G, Owen CD, Resnick E, Strain-Damerell C, Lukacik P, Barr H, Walsh MA, von Delft F, London N Cell Chem Biol. 2021 Jun 22. pii: S2451-9456(21)00263-4. doi:, 10.1016/j.chembiol.2021.05.018. PMID:34174194<ref>PMID:34174194</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 7nw2" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: 2019-ncov]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Aimon A]] | + | [[Category: SARS coronavirus main proteinase]] |
| - | [[Category: Brandao-Neto J]] | + | [[Category: Aimon, A]] |
| - | [[Category: Covid Moonshot | + | [[Category: Brandao-Neto, J]] |
| - | [[Category: Dias A]] | + | [[Category: Consortium, Covid Moonshot]] |
| - | [[Category: Douangamath A]] | + | [[Category: Delft, F von]] |
| - | [[Category: Dunnett L]] | + | [[Category: Dias, A]] |
| - | [[Category: Fearon D]] | + | [[Category: Douangamath, A]] |
| - | [[Category: Gehrtz P]] | + | [[Category: Dunnett, L]] |
| - | [[Category: Gorrie-Stone | + | [[Category: Fearon, D]] |
| - | [[Category: London N]] | + | [[Category: Gehrtz, P]] |
| - | [[Category: Lukacik P]] | + | [[Category: Gorrie-Stone, T J]] |
| - | [[Category: Powell | + | [[Category: London, N]] |
| - | [[Category: Skyner R]] | + | [[Category: Lukacik, P]] |
| - | [[Category: Strain-Damerell | + | [[Category: Powell, A J]] |
| - | [[Category: Walsh | + | [[Category: Skyner, R]] |
| - | [[Category: Zaidman D]] | + | [[Category: Strain-Damerell, C M]] |
| - | [[Category: | + | [[Category: Walsh, M A]] |
| + | [[Category: Zaidman, D]] | ||
| + | [[Category: Diamond i04-1]] | ||
| + | [[Category: Fragment screening]] | ||
| + | [[Category: Hydrolase]] | ||
Revision as of 14:17, 29 December 2021
Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-47
| |||||||||||
Categories: 2019-ncov | Large Structures | SARS coronavirus main proteinase | Aimon, A | Brandao-Neto, J | Consortium, Covid Moonshot | Delft, F von | Dias, A | Douangamath, A | Dunnett, L | Fearon, D | Gehrtz, P | Gorrie-Stone, T J | London, N | Lukacik, P | Powell, A J | Skyner, R | Strain-Damerell, C M | Walsh, M A | Zaidman, D | Diamond i04-1 | Fragment screening | Hydrolase
